A study of self-management interventions for neurogenic bladder patients based on symptom management theory.

IF 2.1 4区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Trials Pub Date : 2026-07-13 DOI:10.1186/s13063-026-09894-y

Xiaomei Li, Xixi Li, Chun Li, Wei Lin

{"title":"A study of self-management interventions for neurogenic bladder patients based on symptom management theory.","authors":"Xiaomei Li, Xixi Li, Chun Li, Wei Lin","doi":"10.1186/s13063-026-09894-y","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the clinical efficacy of a self‑management intervention programme based on symptom management theory for patients with neurogenic bladder (NB).Methods: One hundred NB patients treated at a rehabilitation centre between May 2023 and May 2025 who met the inclusion criteria were randomly assigned to two groups (n = 50 each). The control group received routine nursing care, while the observation group received the theory‑based self‑management intervention. Outcomes included self‑management capability, quality of life, voiding parameters (bladder capacity, residual urine volume, daily voiding frequency), NB symptoms, anxiety/depression, and neurogenic bowel function.Results: After 4 weeks, the observation group showed higher self‑management scores and bladder capacity than the control group [57 (49,66) vs. 35 (28,42) points; (376.18 ± 59.65) vs. (224.38 ± 38.13) mL], and lower quality‑of‑life scores, residual urine volume, and daily voiding frequency [(15.10 ± 5.12) vs. (22.02 ± 5.64) points; (103.56 ± 24.25) vs. (155.18 ± 57.43) mL; (9.72 ± 2.33) vs. (17.52 ± 2.87) times; all P < 0.05]. Symptom scores (NBSS, NBDS, SAS, SDS) were also lower in the observation group (P < 0.05).Conclusion: The programme enhances self‑management, improves bladder function, alleviates symptoms, and increases quality of life in NB patients.","PeriodicalId":23333,"journal":{"name":"Trials","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2026-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13640200/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13063-026-09894-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To evaluate the clinical efficacy of a self‑management intervention programme based on symptom management theory for patients with neurogenic bladder (NB).

Methods: One hundred NB patients treated at a rehabilitation centre between May 2023 and May 2025 who met the inclusion criteria were randomly assigned to two groups (n = 50 each). The control group received routine nursing care, while the observation group received the theory‑based self‑management intervention. Outcomes included self‑management capability, quality of life, voiding parameters (bladder capacity, residual urine volume, daily voiding frequency), NB symptoms, anxiety/depression, and neurogenic bowel function.

Results: After 4 weeks, the observation group showed higher self‑management scores and bladder capacity than the control group [57 (49,66) vs. 35 (28,42) points; (376.18 ± 59.65) vs. (224.38 ± 38.13) mL], and lower quality‑of‑life scores, residual urine volume, and daily voiding frequency [(15.10 ± 5.12) vs. (22.02 ± 5.64) points; (103.56 ± 24.25) vs. (155.18 ± 57.43) mL; (9.72 ± 2.33) vs. (17.52 ± 2.87) times; all P < 0.05]. Symptom scores (NBSS, NBDS, SAS, SDS) were also lower in the observation group (P < 0.05).

Conclusion: The programme enhances self‑management, improves bladder function, alleviates symptoms, and increases quality of life in NB patients.

查看原文本刊更多论文

基于症状管理理论的神经源性膀胱患者自我管理干预研究。

目的：评价基于症状管理理论的自我管理干预方案对神经源性膀胱（NB）患者的临床疗效。方法：于2023年5月至2025年5月在某康复中心治疗的100例NB患者符合纳入标准，随机分为两组（n = 50）。对照组给予常规护理，观察组给予基于理论的自我管理干预。结果包括自我管理能力、生活质量、排尿参数（膀胱容量、剩余尿量、每日排尿频率）、NB症状、焦虑/抑郁和神经源性肠功能。结果：4周后，观察组的自我管理评分和膀胱容量均高于对照组[57（49,66）比35（28,42）分；（376.18±59.65）比（224.38±38.13）mL]，生活质量评分、剩余尿量和每日排尿次数较低[（15.10±5.12）比（22.02±5.64）分；（103.56±24.25）vs(155.18±57.43)mL；（9.72±2.33）∶（17.52±2.87）倍；结论：该方案增强了NB患者的自我管理，改善了膀胱功能，缓解了症状，提高了生活质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trials 医学-医学：研究与实验

CiteScore

3.80

自引率

4.00%

发文量

966

审稿时长

6 months

期刊介绍： Trials is an open access, peer-reviewed, online journal that will encompass all aspects of the performance and findings of randomized controlled trials. Trials will experiment with, and then refine, innovative approaches to improving communication about trials. We are keen to move beyond publishing traditional trial results articles (although these will be included). We believe this represents an exciting opportunity to advance the science and reporting of trials. Prior to 2006, Trials was published as Current Controlled Trials in Cardiovascular Medicine (CCTCVM). All published CCTCVM articles are available via the Trials website and citations to CCTCVM article URLs will continue to be supported.